BCL2 protein expression in DLBCL can be caused by different genetic events such as translocations, mutations, gains, and amplifications as well as transcriptional upregulation from pathways discussed later (BCR signaling and NF-kB) (Table 2) [31]. The gene discussed is NFKB1; the disease is diffuse large B-cell lymphoma.